Tech outperforms after jumbo Fed rate cut: Are bullish signals coming?
Views 1.5M
Contents 534
Today's Pre-Market Movers and Top Ratings | CRM, TSLA, PINS, DE, and More
$Salesforce (CRM.US)$ stock rises 1.7% following Piper Sandler upgrade to 'overweight,' citing potential doubling of free cash flow per share by 2029.
$Tesla (TSLA.US)$ stock increased by 0.9% as Barclays projected an 8% year-over-year rise in the EV manufacturer's third-quarter deliveries, estimating approximately 470,000 units.
$Lowe's Companies (LOW.US)$ stock increased by 1.6% after Oppenheimer upgraded its rating of the retailer to "outperform" from "perform," citing the tendency for demand trends in home improvement to improve as lending rates moderate.
$Pinterest (PINS.US)$ saw its stock rise by over 1% after Oppenheimer initiated coverage with an "outperform" rating. The investment firm highlighted Pinterest's robust advertising business and its integration with major e-commerce platforms as key drivers for future growth.
$Deere (DE.US)$ stock dropped by 1.1% after former President Donald Trump threatened the agricultural manufacturer with a "200% tariff" on Monday if it relocates some production to factories in Mexico.
$Visa (V.US)$ stock declined by 1.9% as the U.S. Department of Justice prepared to file an antitrust lawsuit against the credit card giant, alleging anti-competitive behavior.
$Snowflake (SNOW.US)$ stock dropped by 3.5% following the cloud data storage company's announcement of a planned $2 billion private placement of convertible notes.
$Starbucks (SBUX.US)$ stock fell by 1.6% after Jefferies downgraded it from "hold" to "underperform" and lowered its price target. The firm cited low visibility in both the U.S. and China in the near term and anticipated reductions in estimates for the near- and medium-term.
Source: CNBC; Investing.com
US Top Rating Updates on 09/24
Disclaimer: Moomoo Technologies Inc. is providing this content for information and educational use only.
Read more14
Growth Investor27 : Check out Esperion ESPR, it is a very cheap stock that sells newly FDA approved statin alternative drugs NEXLETOL and NEXLIZET . I take Nexlizet, my insurance just started covering it this month. Script sales will be very large
103138533 : !!!!!